Lamotrigin Aristo

Lamotrigine, the active ingredient in Lamotrigin Aristo, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat epilepsy, bipolar disorder and to prevent migraine attacks in adults. GNH USA supplies Lamotrigin Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is employed across several neurological and psychiatric conditions where abnormal neuronal excitability is a key factor. - Epilepsy: reduces the frequency and severity of seizures. - Bipolar disorder: stabilises mood and helps prevent depressive episodes. - Migraine prevention: decreases the number of migraine attacks.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions such as bullous eruptions - Blood dyscrasias (e.g., agranulocytosis) - Hepatic failure - Suicidal thoughts or behaviour

Patients should be monitored for specific safety concerns before and during therapy. - Monitor blood counts: perform periodic complete blood count tests. - Assess liver function: check hepatic enzymes regularly. - Avoid abrupt discontinuation: taper the dose under medical supervision. - Caution in cardiac conduction disorders: consider ECG monitoring. - Store at room temperature: keep in the original container, protect from moisture.

Lamotrigine can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Valproate: can raise lamotrigine levels, increasing toxicity risk. - Carbamazepine: reduces lamotrigine concentrations, potentially lowering efficacy. - Phenobarbital: decreases lamotrigine exposure, possibly leading to treatment failure.

Moderate Interactions (Monitor Closely): - Oral contraceptives: increase lamotrigine clearance, may require dose adjustment. - Serotonergic agents: heightened risk of serotonin syndrome. - Other antiepileptic drugs: may necessitate therapeutic drug monitoring.